title: Eosinophilic Infiltrates in Vemurafenib-Associated Verrucous Keratoses.
authors.affiliation: Departments of *Pathology, and †Dermatology, University Hospitals Case Medical Center/Case Western Reserve University, Cleveland, OH; and ‡Division of Hematology and Oncology, Department of Internal Medicine, University Hospitals Case Medical Center/Case Western Reserve University, Cleveland, OH.
authors.forename: William D
authors.initials: WD
authors.lastname: Longhurst
authors.forename: Kord
authors.initials: K
authors.lastname: Honda
authors.forename: Henry B
authors.initials: HB
authors.lastname: Koon
authors.forename: Meg R
authors.initials: MR
authors.lastname: Gerstenblith
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D004802:Eosinophilia / Q000139:chemically induced* / Q000473:pathology; D004804:Eosinophils / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007642:Keratosis / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D047428:Protein Kinase Inhibitors; D013449:Sulfonamides; D000077484:Vemurafenib